Brief: Icosavax Initiates Phase 2 Trial Of IVX-A12 Against RSV And HMPV In Older Adults

Icosavax

20/06/2023 14:43

June 20 (Reuters) - Icosavax Inc  ICVX.O :
    * ICOSAVAX INITIATES PHASE 2 TRIAL OF IVX-A12 AGAINST RSV
AND HMPV
IN OLDER ADULTS
    * ICOSAVAX INC - 6-MONTH DURABILITY DATA FOR PHASE 1 TRIAL
OF
IVX-A12 ALSO EXPECTED IN 1Q 2024
    * ICOSAVAX INC - PHASE 2 TOPLINE INTERIM RESULTS EXPECTED IN
1Q
2024

Source text for Eikon:  ID:nGNX3sDNhD 
Further company coverage:  ICVX.O 

 (Reuters.Briefs@thomsonreuters.com)